SCHEMBL6726849

SCHEMBL6726849

[C-]#[N+]c1c(N2CCOCC2)sc(-c2[nH]ncc2C)c1-c1ccc(Cl)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 9/20 0.51
MTOR P42345 3/20 0.51
CRHR1 P34998 1/20 0.40
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
AR P10275 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
CNR2 P34972 3/20 0.35
ALPL P05186 1/20 0.34
PIK3R1 P27986 3/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CB P42338 1/20 0.34
PIK3CG P48736 1/20 0.34
DPP4 P27487 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TP53 P04637 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6752237 0.84 PIK3CA (0.70) PIK3CAMTORCRHR1NPC1RAB9A
SCHEMBL6726831 0.83 PIK3CA (0.57) PIK3CAMTORCRHR1NPC1RAB9A
SCHEMBL6726825 0.80 PIK3CA (0.51) PIK3CAMTORCRHR1NPC1RAB9A
SCHEMBL6726920 0.80 PIK3CA (0.49) PIK3CAMTORCRHR1NPC1RAB9A
SCHEMBL6726842 0.80 PIK3CA (0.55) PIK3CAMTORCRHR1NPC1RAB9A
SCHEMBL6726885 0.80 PIK3CA (0.47) PIK3CAMTORCRHR1NPC1RAB9A
SCHEMBL11903401 0.78 PIK3CA (0.44) PIK3CAMTORCRHR1NPC1RAB9A
SCHEMBL6726840 0.78 PIK3CA (0.55) PIK3CAMTORCRHR1NPC1RAB9A
SCHEMBL6726845 0.78 PIK3CA (0.53) PIK3CAMTORCRHR1NPC1RAB9A
SCHEMBL6726881 0.78 PIK3CA (0.49) PIK3CAMTORCRHR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130217689-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-08-22 US disclosed
US-8440664-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-05-14 US disclosed
US-20120202812-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-08-09 US disclosed
US-8183240-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-05-22 US disclosed
US-20100075951-A1 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075951-A1 Heteroaryls and uses thereof PIK3R3, AKT1S1, PIK3R1 PIK3CA 11/4885MTOR 148/4885CRHR1 1644/4885
US-20130217689-A1 HETEROARYLS AND USES THEREOF PIK3R3, AKT1S1, PIK3R1 PIK3CA 11/4885MTOR 148/4885CRHR1 1644/4885
US-20120202812-A1 HETEROARYLS AND USES THEREOF PIK3R3, AKT1S1, PIK3R1 PIK3CA 11/4885MTOR 148/4885CRHR1 1644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.